Accéder au contenu
Merck

SAR studies of some acetophenone phenylhydrazone based pyrazole derivatives as anticathepsin agents.

Bioorganic chemistry (2017-09-16)
Neera Raghav, Mamta Singh
RÉSUMÉ

Cathepsins have emerged as promising molecular targets in a number of diseases such as Alzeimer's, inflammation and cancer. Elevated cathepsin's levels and decreased cellular inhibitor concentrations have emphasized the search for novel inhibitors of cathepsins. The present work is focused on the design and synthesis of some acetophenone phenylhydrazone based pyrazole derivatives as novel non peptidyl inhibitors of cathepsins B, H and L. The synthesized compounds after characterization have been explored for their inhibitory potency against cathepsins B, H and L. The results show that some of the synthesized compounds exhibit anti-catheptic activity with K

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Nα-Benzoyl-DL-arginine β-naphthylamide hydrochloride, trypsin substrate